Drug Categories | IRs | NO. | TI (m) | Dose | Non- IRs | NO. | TI (h-d) | Dose |
---|---|---|---|---|---|---|---|---|
BLs (20) | Ana | 1 (5%) | 90 | 7/10 | MPE | 5 (25%) | 4:6–8 h/ 2d | 100% |
U | 4 (20%) | < 60 | 7/10 | 1: 6 h/ 3d | ||||
ER | 1 (5%) | < 60 | 7/10 | U | 4 (20%) | 2:6-8 h/4d 1: 6–8 h/1d 1a | 1:7/10 3:100% | |
ER | 3 (15%) | 6–12 h/2d | 100% | |||||
ER+ Diarrhea | 1 (5%) | 6 h/3d | 100% | |||||
ED | 1 (5%) | 8–10 h/1d | 7/10 | |||||
Macrolides (3) | U | 2 (66.7%) | < 60 | 1/10 7/10 | – | – | – | – |
ER + Diarrhea | 1 (33.3%) | 30 | 7/10 | – | – | – | – | |
NSAIDs (11) | A | 4 (36.3%) | < 60 | 7/10 | A | 2 (18.2%) | > 1 h/1d | 7/10 |
UA | 2 (18.2%) | < 60 | 1/10 7/10 | – | – | – | – | |
U | 2 (18.2%) | < 60 | 7/10 | – | – | – | – | |
ER | 1 (9.1%) | < 60 | 7/10 | – | – | – | – | |
Local anesthetics (1) | MPE | 1 (100%) | 10 | 2 ml | – | – | – | – |